Current and future treatments for tuberculosis.

Lee, Anthony; Xie, Yingda Linda; Barry, Clifton E; Chen, Ray Y

Lee, Anthony; Xie, Yingda Linda; Barry, Clifton E; Chen, Ray Y.

Afiliação

Lee A; Medical Research Scholars Program, National Institutes of Health, Bethesda, MD, USA.
Xie YL; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Medicine, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Barry CE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Medicine, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Chen RY; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

BMJ ; 368: m216, 2020 03 02.

Article em En | MEDLINE | ID: mdl-32122882

Assuntos

Antituberculosos/uso terapêutico; Tuberculose/tratamento farmacológico; Humanos; Tuberculose Latente/tratamento farmacológico; Guias de Prática Clínica como Assunto; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Antituberculosos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: BMJ Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google